ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial

MK Yong, K Thursky, M Crane, T Spelman, RK Mahar, JA Simpson, AM Scott, SJ Harrison, J Szer, M Pellegrini, S Lingaratnam, KC Pang, S Tennakoon, BZ Sim, E Blyth, HK Gan, H Quach, MP McIntosh, H Page, R Woolstencroft

2026-02-15

Background We evaluated whether a daily nasal spray of interferon-alpha (IFN-α) would reduce the incidence of COVID-19 or communit..